Summary
This prediction ended on 14.12.22 with a price of €0.39. Massive losses of -62.95% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Balyo | 0.000% | 0.000% | 54.023% | -36.114% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% | 50.820% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% | 90.843% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% | 51.211% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% | 62.945% |
Comments by krebskrebs for this prediction
In the thread Balyo diskutieren
In the thread Trading Balyo
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten